| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.48 | 0.01 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.37 | 0.007 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.37 | 6e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.33 | 2e-07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.29 | 1e-13 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.27 | 7e-11 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.26 | 9e-10 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.26 | 5e-09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.26 | 2e-09 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.25 | 0.3 |